S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Can't believe it's happening again (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Can't believe it's happening again (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Can't believe it's happening again (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Can't believe it's happening again (Ad)
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
The “Perfect Storm” for Gold (Ad)
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
Free Trial

Compare Stocks

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Compare

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$0.26
-3.8%		C$0.26
C$0.15
▼
C$0.53
C$52.28MN/A644,760 shs384,329 shs
13 Stocks Institutional Investors Won't Stop Buying Cover
13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
C$13.02M4.02C$0.33 per share0.78C$0.40 per share0.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A-C$0.70N/A∞N/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
35.45
2.97
2.61

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A

Insider Ownership

CompanyInsider Ownership
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Emerald Health Therapeutics, Inc. stock logo
EMH
Emerald Health Therapeutics
161205.03 millionN/ANot Optionable

EMH and MDG1 Headlines

SourceHeadline
University Hospitals Elyria Medical CenterUniversity Hospitals Elyria Medical Center
health.usnews.com - September 23 at 12:26 AM
Digital Therapeutics: Next wave in managing chronic medical conditionsDigital Therapeutics: Next wave in managing chronic medical conditions
health.economictimes.indiatimes.com - September 13 at 9:19 PM
The Digital Therapeutics Market Is GangbustersThe Digital Therapeutics Market Is Gangbusters
mddionline.com - August 29 at 11:45 PM
Digital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce StudyDigital Therapeutics (DTx) For Mental Health Market is Booming and Expected to Grow at a CAGR of 27.42% to 2031 | InsightAce Study
finance.yahoo.com - July 31 at 12:17 AM
Emerald Isle’s Lee Avenue to close again soon as culvert project restartsEmerald Isle’s Lee Avenue to close again soon as culvert project restarts
carolinacoastonline.com - July 15 at 8:44 AM
Efficient Market Hypothesis (EMH): Definition and CritiqueEfficient Market Hypothesis (EMH): Definition and Critique
investopedia.com - July 12 at 2:56 PM
Revolutionizing mental health treatment: Vistagen Therapeutics nasal spray solutionRevolutionizing mental health treatment: Vistagen Therapeutics' nasal spray solution
finance.yahoo.com - June 20 at 12:36 PM
Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023Menarini Group Shares New Analysis from EMERALD Clinical Study of ORSERDU® (Elacestrant) in Metastatic Breast Cancer at ASCO 2023
thaipr.net - May 29 at 4:23 AM
Emerald Care Center TulsaEmerald Care Center Tulsa
health.usnews.com - May 4 at 11:26 PM
Emerald ReegEmerald Reeg
health.usnews.com - April 25 at 7:35 AM
Emerald Expositions GAAP EPS of $0.06, revenue of $93.6MEmerald Expositions GAAP EPS of $0.06, revenue of $93.6M
msn.com - March 14 at 9:07 AM
Tahoes Emerald Bay freezes over for first time in decades amid atmospheric riverTahoe's Emerald Bay freezes over for first time in decades amid atmospheric river
sfgate.com - March 13 at 4:02 AM
Visus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care ConferenceVisus Therapeutics to Attend TD Cowen’s 43rd Annual Health Care Conference
venturebeat.com - March 4 at 6:25 PM
Emerald community raising money for local dialysis services after political campaigns failEmerald community raising money for local dialysis services after political campaigns fail
abc.net.au - February 25 at 12:07 AM
New Digital Therapeutics Company Takes a Swing at FibromyalgiaNew Digital Therapeutics Company Takes a 'Swing' at Fibromyalgia
mddionline.com - February 22 at 11:25 PM
Emerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment YearEmerald Asset Management PA, LLC 30th Annual Emerald Groundhog Day Investment Forum Opens Amid a Stormy 2023 Investment Year
finance.yahoo.com - January 14 at 1:43 PM
Emerald Health Therapeutics Inc (TBD.BE)Emerald Health Therapeutics Inc (TBD.BE)
finance.yahoo.com - January 4 at 3:42 AM
Emerald Health Therapeutics Announces Revocation of Management Cease Trade OrderEmerald Health Therapeutics Announces Revocation of Management Cease Trade Order
finance.yahoo.com - July 12 at 9:36 AM
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate UpdateEmerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
finance.dailyherald.com - July 4 at 7:56 AM
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
finance.yahoo.com - June 16 at 8:02 AM
Emerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status UpdateEmerald Health Therapeutics, Inc. Provides Bi-Weekly MCTO Status Update
stockhouse.com - May 16 at 4:37 PM
Skye Bioscience Signs Arrangement Agreement with Emerald Health TherapeuticsSkye Bioscience Signs Arrangement Agreement with Emerald Health Therapeutics
nz.finance.yahoo.com - May 12 at 9:26 AM
Cannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQBCannabis Stock News: Emerald Health Therapeutics, Inc. (CSE: EMH) Transfers US Listing to OTCQB
investorideas.com - May 6 at 10:47 AM
Emperor Oil Ltd (EMh)Emperor Oil Ltd (EMh)
investing.com - January 5 at 8:00 AM

Company Descriptions

Emerald Health Therapeutics logo

Emerald Health Therapeutics

CVE:EMH
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Vancouver, Canada.